Aerovate Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Aerovate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aerovate Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aerovate Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $96k | 38k | 2.51 |
| 2024-12-31 | $391k | 147k | 2.65 |
| 2024-09-30 | $103k | 49k | 2.09 |
| 2024-06-30 | $69k | 42k | 1.66 |
| 2023-06-30 | $5.0M | 292k | 17.15 |
| 2022-12-31 | $46M | 1.6M | 29.30 |
| 2022-06-30 | $25M | 1.6M | 15.63 |
| 2022-03-31 | $29M | 1.6M | 18.33 |
| 2021-12-31 | $19M | 1.6M | 11.79 |
| 2021-09-30 | $34M | 1.6M | 21.01 |
| 2021-06-30 | $34M | 1.6M | 21.05 |